article thumbnail

The critical role of the generics sector during the pandemic

pharmaphorum

Despite this, the role of generics can often be overlooked, however its performance during this crisis has demonstrated its crucial importance and ability to respond to a series of considerable challenges. The generics medicines sector can, too, play a substantial part in discovering new areas for licensed products to be used in.

article thumbnail

CHMP meeting highlights: January 2024

European Pharmaceutical Review

The European Medicine Agency’s human medicines committee (CHMP) recommended marketing authorisations for the regulatory approval of three medicines at its January 2024 meeting last week. Additionally, a positive opinion for Niapelf (paliperidone), a generic medicine for schizophrenia was adopted in the meeting.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CHMP meeting highlights: April 2024

European Pharmaceutical Review

The committee also recommended the biosimilar medicine Wezenla (ustekinumab) to treat of plaque psoriasis. Generic medicine Eribulin Baxter (eribulin) was also granted a positive opinion by the committee, to treat breast cancer and liposarcoma. This covers paediatric plaque psoriasis, psoriatic arthritis and Crohn’s disease.

article thumbnail

Inflation threatens supply of life-saving generics to Europe

Pharmaceutical Technology

These factors combined affect the commercial viability of generic medicines, with some European drugmakers already warning that they may stop making cheap generic medicines.

article thumbnail

Supply chain middlemen ‘pocket half of US branded medicine spending’

pharmaphorum

Over the same period, total gross expenditures on brand and generic medicines nearly doubled – from $268 billion to $517 billion, according to the report. The argument has been made that reducing or eliminating rebates could result in lower list prices, and reduce out-of-pocket expenses for patients. ” says the report.

article thumbnail

Medicine and medical device shortages: what’s been done and what’s to do

Hospital Pharmacy Europe

Shortages of medicines and medical devices are a matter of great concern to healthcare professionals, says Tiene Bauters PharmD PhD, Pharmacy Department, Ghent University Hospital, Belgium, as she offers her take on tackling this issue in Europe to maintain a strong medicines supply.

article thumbnail

Breo Ellipta alternatives: What can I take instead of Breo Ellipta?

The Checkup by Singlecare

This combination inhaler is also available as a generic medicine called fluticasone furoate and vilanterol , which are the names of the two medicines in the inhaler. Combination medications, like Symbicort , can help reduce COPD exacerbations that could lead to hospitalizations.